Topics:

Oncology and Hematology News and Journal Articles

Frontline Nivolumab Prolongs Survival in Advanced Melanoma

The PD-1 inhibitor nivolumab increased progression-free and overall survival compared with chemo in patients with previously untreated metastatic melanoma.

Recent Content

The FDA has expanded the approved use of ibrutinib (Imbruvica) to include patients with previously treated Waldenström macroglobulinemia, a rare lymphoma.

The benefit of hypofractionated radiotherapy for women receiving breast-conserving therapy for early-stage breast cancer is becoming more apparent.

Using genome-wide association studies, researchers have identified a germline variant that is associated with intolerance to mercaptopurine in pediatric ALL.

Adding molecular breast imaging to mammography resulted in a fourfold increase in invasive breast cancer detection rates in women with dense breasts.

Prostate cancer patients who smoke may be more susceptible to complications from treatment, and have increased risk of side effects and disease recurrence.

Consumption of four or more cups of caffeinated coffee per day was associated with a 20% decreased risk for malignant melanoma, according to a recent study.

A 47-year-old woman is found to have a mass in the left atrium of her heart. What is your diagnosis?

By clicking Accept, you agree to become a member of the UBM Medica Community.